Short term effects of levothyroxine treatment in thyroid multinodular disease

Endocrine Journal

Volumn 57, Issue 9, 2010, Pages 803-809

  Cesareo, Roberto ^a   Iozzino, Mario ^a   Isgrò, Maria Antonietta ^b   Annunziata, Francesca ^b   di Stasio, Enrico ^b  

^a SANTA MARIA GORETTI HOSPITAL   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Levothyroxine therapy; Multinodular goiter; Pre menopausal women; Thyroid

Indexed keywords

LEVOTHYROXINE; THYROTROPIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MONITORING; ECHOGRAPHY; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; THYROID MULTINODULAR DISEASE; THYROID NODULE; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; TUMOR GROWTH; TUMOR VOLUME;

ADULT; FEMALE; GOITER, NODULAR; HUMANS; MIDDLE AGED; PREMENOPAUSE; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 77957726979     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K10E-144     Document Type: Article

References (36)

1. Cooper DS (1995) Clinical review 66: Thyroxine suppression therapy for benign nodular disease. J Clin Endocrinol Metab 80: 331-334.
2. Giuffrida D and Gharib H (1995) Controversies in the management of cold, hot, and occult thyroid nodules. Am J Med 99: 642-650.
3. Mandel SJ, Brent GA and Larsen PR (1993) Levothyroxine therapy in patients with thyroid disease. Ann Intern Med 119: 492-502.
4. Mazzaferri EL, de los Santos ET and Rofagha-Keyhani S (1988) Solitary thyroid nodule: diagnosis and management. Med Clin North Am 72: 1177-1211.
5. Ross DS, Neer RM, Ridgway EC and Daniels GH (1987) Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med 82: 1167-1170.
6. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ and D'Agostino RB (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331: 1249-1252.
7. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP and Perret GY (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81: 4278-4289.
8. Biondi B, Fazio S, Cuocolo A, Sabatini D, Nicolai E, Lombardi G, Salvatore M and Sacca L (1996) Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J Clin Endocrinol Metab 81: 4224-4228.
9. Biondi B and Cooper DS (2008) The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29: 76-131.
10. Cheung PS, Lee JM and Boey JH (1989) Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study. World J Surg 13: 818-821; discussion 822.
11. Jarlov AE, Hegedus L, Gjorup T and Hansen JM (1991) Observer variation in the clinical assessment of the thyroid gland. J Intern Med 229: 159-161.
12. Celani MF (1993) Levothyroxine suppressive therapy in the medical management of nontoxic benign multinodular goiter. Exp Clin Endocrinol 101: 326-332.
13. Berghout A, Wiersinga WM, Drexhage HA, Smits NJ and Touber JL (1990) Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goiter. Lancet 336: 193-197.
14. Lima N, Knobel M, Cavaliere H, Sztejnsznajd C, Tomimori E and Medeiros-Neto G (1997) Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 7: 691-697.
15. Wesche MF, Tiel VBMM, Lips P, Smits NJ and Wiersinga WM (2001) A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 86: 998-1005.
16. Freitas JE (2000) Therapeutic options in the management of toxic and nontoxic nodular goiter. Semin Nucl Med 30: 88-97.
17. Cattaneo F, Burgi U and Mueller B (1999) [Goiter and nodular thyroid disease: clinical guidelines for diagnosis and treatment (Waiting? Hormone therapy? Surgery? radioiodine?)]. Ther Umsch 56: 356-363.
18. Paggi A, Persegani-Trimarchi C, Russo P, Mastropasqua M, Mosetti MA, Losi T and Leri O (1999) Solitary nodular disease and multinodular goiter: a retrospective study on suppressive versus replacement levothyroxine therapy. Endocr Res 25: 229-238.
19. Giordano G (1996) [Medical treatment of multinodular goiter]. Ann Ital Chir 67: 327-334.
20. Shabana W, Peeters E and De Maeseneer M (2006) Measuring thyroid gland volume: should we change the correction factor? AJR Am J Roentgenol 186: 234-236.
21. Sandell EB and Kolthoff IM (1937) Micro determination of iodine by a catalytic method. Mikrochemica Acta 1 9-25.
22. Ivanac G, Rozman B, Skreb F, Brkljacic B and Pavic L (2004) Ultrasonographic measurement of the thyroid volume. Coll Antropol 28: 287-291.
23. Dumont JE, Maenhaut C, Pirson I, Baptist M and Roger PP (1991) Growth factors controlling the thyroid gland. Baillieres Clin Endocrinol Metab 5: 727-754.
24. Studer H and Derwahl M (1995) Mechanisms of nonneoplastic endocrine hyperplasia--a changing concept: a review focused on the thyroid gland. Endocr Rev 16: 411-426.
25. Sadoul JL (1995) [Genesis of thyroid nodules. Physiological and pathological mechanisms, clinical implications]. Ann Endocrinol (Paris) 56: 5-22.
26. Morosini PP, Taccaliti A, Montironi R, Scarpelli M, Diamanti L, Simonella G, Mancini V, Petrelli MD and Mantero F (1996) TGF-beta 1 immunohistochemistry in goiter: comparison of patients with recurrence or no recurrence. Thyroid 6: 417-422.
27. Celani MF, Mariani M and Mariani G (1990) On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid, thyroid nodules. Acta Endocrinol (Copenh) 123: 603-608.
28. La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R and Belfiore A (1995) Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 122: 1-8.
29. Papini E, Bacci V, Panunzi C, Pacella CM, Fabbrini R, Bizzarri G, Petrucci L, Giammarco V, La Medica P, Masala M et al. (1993) A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules. Clin Endocrinol (Oxf) 38: 507-513.
30. Gharib H, James EM, Charboneau JW, Naessens JM, Offord KP and Gorman CA (1987) Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 317: 70-75.
31. Reverter JL, Lucas A, Salinas I, Audi L, Foz M and Sanmarti A (1992) Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf) 36: 25-28.
32. Wemeau JL, Caron P, Schvartz C, Schlienger JL, Orgiazzi J, Cousty C and Vlaeminck-Guillem V (2002) Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab 87: 4928-4934.
33. Gharib H and Mazzaferri EL (1998) Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 128: 386-394.
34. Csako G, Byrd D, Wesley RA, Sarlis NJ, Skarulis MC, Nieman LK and Pucino F (2000) Assessing the effects of thyroid suppression on benign solitary thyroid nodules. A model for using quantitative research synthesis. Medicine (Baltimore) 79: 9-26.
35. Zelmanovitz F, Genro S and Gross JL (1998) Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 83: 3881-3885.
36. Elte JW, Bussemaker JK and Haak A (1990) The natural history of euthyroid multinodular goiter. Postgrad Med J 66: 186-190.